Autologous transplantation in poor risk Hodgkin's disease using high dose melphalan/etoposide conditioning with non-cryopreserved marrow rescue. The Newcastle and Northern Region Lymphoma Group.

This study aimed to assess the safety and efficacy of using high dose melphalan and etoposide followed by autologous, non-cryopreserved marrow rescue in advanced Hodgkin's disease (HD). Seventeen patients with poor risk Hodgkin's disease from a single centre underwent autologous bone marro...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Taylor, P. R., Jackson, G. H., Lennard, A. L., Lucraft, H., Proctor, S. J.
Formato: Artigo
Idioma:Inglês
Publicado: Nature Publishing Group 1993
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC1968195/
https://ncbi.nlm.nih.gov/pubmed/8431371
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares